Program reimburses pharmacists who counsel patients on glyburide product.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004345:Drug Industry; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D010353:Patient Education as Topic; D010595:Pharmacists; D012052:Reimbursement, Incentive
D005905:Glyburide